PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsrhinitis
MeSH D012220 - rhinitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012141:Respiratory tract infections
$
Success rate
D009668:Nose diseases
0 Companies
0 Drugs
Success rate
D012220: 
Rhinitis
D000096825:Rhinosinusitis
0 Companies
0 Drugs
Success rate
D012222:Atrophic rhinitis
0 Companies
0 Drugs
Success rate
D012223:Vasomotor rhinitis
D065631:Allergic rhinitis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaPseudoephedrine, TRIPROLIDINE Triphed  1984-05-17   
Pseudoephedrine, TRIPROLIDINE Triprolidine Pseudoephedrine  1984-12-12   
Taro PharmaceuticalOxymetazoline Oxymetazoline  2021-10-04   
XiromedEphedrine Ephedrine  2022-04-21   
Johnson & JohnsonOxymetazoline Visine  1989-03-31   
GSKTRIPROLIDINE Actidil  1983-07-01   
Pseudoephedrine, Codeine, TRIPROLIDINE Actifed  1984-04-04   
SandozEphedrine Ephedrine  2017-08-23   
Pseudoephedrine, TRIPROLIDINE Pseudoephedrine Triprolidine  1983-05-17   
NovartisChlorpheniramine, Phenylpropanolamine Triaminic  1982-01-01   
AlpharmaHydrocodone, Phenylpropanolamine Codamine  2000-09-29   
TRIPROLIDINE Triprolidine  1982-01-01   
AllerganTRIPROLIDINE Triprolidine  1982-01-01   
Pseudoephedrine, TRIPROLIDINE Triprolidine Pseudoephedrine  1984-01-13   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
100%
7/7
Phase 2
57%
8/14
Phase 3
41%
13/32
Approved: 5Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Taro Pharmaceutical
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use